BAX

19.53

1.98% 0.38

Dopo l'orario di chiusura: 19.60 0.07 +0.36%

Baxter International Inc (BAX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché BAX Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$19.15

Aprire:

$19.25

Volume 24 ore:

9.14M

Relative Volume:

1.20

Capitalizzazione di mercato:

$10.04B

Reddito:

$10.89B

Utile/perdita netta:

$-241.00M

Rapporto P/E:

-73.53

EPS:

-0.2656

Flusso di cassa netto:

$340.00M

1 W Prestazione:

+7.54%

1M Prestazione:

+5.74%

6M Prestazione:

-36.22%

1 anno Prestazione:

-35.59%

Intervallo 1D:

$19.12

$19.82

Intervallo di 1 settimana:

$17.92

$19.82

Portata 52W:

$17.40

$37.74

Baxter International Inc Stock (BAX) Company Profile

Nome

Baxter International Inc

Settore

Healthcare (1131)

Industria

Medical Instruments & Supplies (56)

Telefono

(224) 948-2000

Indirizzo

ONE BAXTER PARKWAY, DEERFIELD, IL

Dipendente

38,000

Cinguettio

@baxter_intl

Prossima data di guadagno

2024-11-08

Ultimi documenti SEC

BAX's Discussions on Twitter

Confronta BAX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BAX Baxter International Inc	19.53	9.84B	10.89B	-241.00M	340.00M	-0.2656
ISRG Intuitive Surgical Inc	559.52	192.25B	9.61B	2.77B	2.27B	7.555
BDX Becton Dickinson Co	200.09	57.34B	21.84B	1.68B	2.67B	5.8293
ALC Alcon Inc	79.19	38.71B	10.19B	1.05B	1.38B	2.1044
RMD Resmed Inc	253.07	36.82B	5.26B	1.44B	1.76B	9.7713
WST West Pharmaceutical Services Inc	271.86	19.25B	2.96B	487.70M	344.00M	6.6758

Baxter International Inc Stock (BAX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-10-31	Downgrade	Argus	Buy → Hold
2025-08-04	Downgrade	Stifel	Buy → Hold
2025-08-01	Downgrade	Goldman	Buy → Neutral
2025-02-26	Ripresa	Goldman	Buy
2025-02-24	Aggiornamento	Argus	Hold → Buy
2025-02-20	Ripresa	Barclays	Overweight
2024-07-15	Downgrade	Morgan Stanley	Equal-Weight → Underweight
2024-05-30	Iniziato	Goldman	Neutral
2024-05-10	Downgrade	TD Cowen	Buy → Hold
2023-05-30	Ripresa	Morgan Stanley	Equal-Weight
2023-03-29	Iniziato	UBS	Neutral
2023-01-06	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2023-01-05	Downgrade	Raymond James	Outperform → Mkt Perform
2023-01-03	Downgrade	BofA Securities	Buy → Neutral
2022-12-19	Downgrade	JP Morgan	Overweight → Neutral
2022-12-15	Downgrade	Deutsche Bank	Buy → Hold
2022-12-12	Downgrade	Citigroup	Buy → Neutral
2022-10-18	Iniziato	Barclays	Overweight
2022-10-12	Iniziato	Jefferies	Hold
2022-06-24	Downgrade	Wells Fargo	Overweight → Equal Weight
2022-04-04	Downgrade	Goldman	Neutral → Sell
2022-03-02	Ripresa	BofA Securities	Buy
2022-02-18	Reiterato	KeyBanc Capital Markets	Overweight
2022-02-18	Reiterato	Morgan Stanley	Overweight
2022-02-18	Reiterato	Raymond James	Outperform
2022-02-18	Reiterato	Stifel	Buy
2022-02-18	Reiterato	UBS	Neutral
2022-02-18	Reiterato	Wells Fargo	Overweight
2022-02-11	Iniziato	Goldman	Neutral
2022-01-07	Ripresa	Citigroup	Buy
2022-01-07	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2021-09-13	Aggiornamento	Cowen	Market Perform → Outperform
2021-09-03	Aggiornamento	Barclays	Equal Weight → Overweight
2021-05-25	Iniziato	Barclays	Equal Weight
2021-01-29	Downgrade	Piper Sandler	Overweight → Neutral
2021-01-06	Downgrade	UBS	Buy → Neutral
2020-12-15	Downgrade	Goldman	Buy → Neutral
2020-10-01	Aggiornamento	Citigroup	Neutral → Buy
2020-09-04	Downgrade	Argus	Buy → Hold
2020-06-24	Iniziato	Oppenheimer	Outperform
2020-03-19	Aggiornamento	Stifel	Hold → Buy
2020-03-18	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2020-03-05	Iniziato	Citigroup	Neutral
2020-02-13	Iniziato	Goldman	Buy
2020-01-02	Aggiornamento	Evercore ISI	In-line → Outperform
2019-12-17	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2019-06-26	Iniziato	KeyBanc Capital Markets	Sector Weight
2019-04-08	Downgrade	Evercore ISI	Outperform → In-line
2019-01-02	Aggiornamento	Citigroup	Neutral → Buy
2019-01-02	Aggiornamento	Morgan Stanley	Underweight → Overweight
2018-11-02	Aggiornamento	Argus	Hold → Buy
2018-10-16	Iniziato	Barclays	Underweight
2018-05-17	Ripresa	Piper Jaffray	Overweight
2018-02-06	Reiterato	Citigroup	Neutral
2018-01-03	Iniziato	Evercore ISI	Outperform
2018-01-03	Aggiornamento	Raymond James	Mkt Perform → Outperform

Mostra tutto

Baxter International Inc Borsa (BAX) Ultime notizie

Dec 15, 2025

BAXTER CLASS ACTION DEADLINE 12/15: Bragar Eagel & Squire, - GlobeNewswire

Dec 15, 2025

BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire

Dec 15, 2025

Portnoy Law Firm Announces Class Action on Behalf of Baxter International, Inc. Investors - GlobeNewswire

Dec 15, 2025

BAX Highlights EMR-Integrated Smart Pumps Boost Patient Safety & Care - TradingView — Track All Markets

Dec 15, 2025

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International - Rutland Herald

Dec 15, 2025

Investors who lost money on Baxter International, Inc.(BAX) should contact The Gross Law Firm about pending Class ActionBAX - PR Newswire

Dec 15, 2025

Baxter Presents Real-World Data at American Society of Health System Pharmacists Meeting Demonstrating Smart Infusion Pump Electronic Medical Record (EMR) Integration May Improve Patient Safety and Nursing Bedside Productivity - Bioscience Association Manitoba

Dec 15, 2025

Cullen Capital Management LLC Grows Position in Baxter International Inc. $BAX - Defense World

Dec 15, 2025

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Baxter International Inc. with Losses of $100,000 to Contact the Firm - PR Newswire

Dec 15, 2025

Dec 14, 2025

BAX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Dec 14, 2025

Class Action Alert: Levi & Korsinsky Reminds Baxter International, Inc. (BAX) Investors of December 15, 2025 Deadline - Stockhouse

Dec 14, 2025

BAX DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that Baxter Investors Have Opportunity to Lead Class Action Lawsuit - marketscreener.com

Dec 14, 2025

Dec 13, 2025

BAXTER CLASS ACTION DEADLINE: Bragar Eagel & Squire, P.C. - GlobeNewswire

Dec 13, 2025

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Baxter Investors Have Opportunity to Lead Class Action Lawsuit - TMX Newsfile

Dec 13, 2025

Dec 12, 2025

Investors in Baxter International, Inc. Should Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your RightsBAX - Your Wyoming Link

Dec 12, 2025

Deadline Soon: Baxter International, Inc. (BAX) Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - Business Wire

Dec 12, 2025

BAX DEADLINE: Faruqi & Faruqi Reminds Baxter Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 12, 2025BAX - Morningstar

Dec 12, 2025

Syringe Pumps Industry Intelligence Report 2025-2032: Focus on Product Types, Material Types, Mode of Operation, End Users, Regions, Groups, Countries - GlobeNewswire Inc.

Dec 12, 2025

Wells Fargo Adjusts PT on Baxter International to $19 From $21, Maintains Equalweight Rating - marketscreener.com

Dec 12, 2025

Wells Fargo Maintains Baxter International Inc(BAX.US) With Hold Rating, Cuts Target Price to $19 - 富途牛牛

Dec 12, 2025

Parkwood LLC Makes New $9.46 Million Investment in Baxter International Inc. $BAX - MarketBeat

Dec 12, 2025

Baxter International Stock: Is BAX Underperforming the Health Care Sector? - Barchart.com

Dec 12, 2025

Dec 11, 2025

Is Baxter International Offering Long Term Value After Years of Share Price Declines? - Yahoo Finance

Dec 11, 2025

BAX Deadline: BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit - PR Newswire

Dec 11, 2025

Baxter Presents Real-World Data at American Society of Health System Pharmacists Meeting Demonstrati - pharmiweb.com

Dec 11, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire

Dec 11, 2025